Перевести на Переведено сервисом «Яндекс.Перевод»

Nymox Pharmaceutical

Country
Canada
Краткое название
Nymox Pharmaceutical
Headquarters
9900 Cavendish Boulevard Suite 306
Members of the board

Paul Averback, MD, DABP,
President and CEO
Roy M. Wolvin, B.A.(Econ.),
Secretary-Treasurer and Chief Financial Officer
Jack Gemmell, B.Sc.(Hons.), LL.B.,
General Counsel and Chief Information Officer
Brian Doyle, B.Sc., M.B.A.,
Director of Business Development

Categories medicine
Neurology, Oncology
Stage of the project
Production
Disease
Intestine cancer, Alzheimer disease
Ticker
NYMX
Current owners

Paul Averback, MD, DABP,
President and CEO, Chairman of the Board
Randall Lanham,
Independent Director
Paul F. McDonald,
Independent Director
Professor David Morse,
Independent Director
Roger Guy, M.D.,
Independent Director
Jack Gemmell,
General Counsel and Chief Information Officer

Assets
53.1800
Technology
Cell Technologies, Pharmaceuticals, Chemistry